Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65296-80-2

Post Buying Request

65296-80-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Platinum,[1,2-benzenedicarboxylato(2-)-kO1,kO2](1,2-cyclohexanediamine-kN,kN')-, (SP-4-2)-

    Cas No: 65296-80-2

  • No Data

  • No Data

  • No Data

  • yuyongmei
  • Contact Supplier

65296-80-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 65296-80-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,2,9 and 6 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 65296-80:
(7*6)+(6*5)+(5*2)+(4*9)+(3*6)+(2*8)+(1*0)=152
152 % 10 = 2
So 65296-80-2 is a valid CAS Registry Number.

65296-80-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-azanidylcyclohexyl)azanide,phthalic acid,platinum(2+)

1.2 Other means of identification

Product number -
Other names Platinum,2-benzenedicarboxylato(2-)-O1,O2](1,2-cyclohexanediamine-N,N')-,(SP-4-2)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65296-80-2 SDS

65296-80-2Downstream Products

65296-80-2Relevant articles and documents

Design, synthesis and in-vitro cytotoxicity of novel platinum (II) complexes with phthalate as the leaving group

Sharma, Rajiv,Rawal, Ravindra K.,Malhotra, Manav,Gaba, Tripti,Sharma,Bhardwaj

, p. 872 - 878 (2013/12/04)

Three platinum (II) complexes (6-8) with phthalate as the leaving group were synthesized and characterized by FTIR, 1H NMR, 13C NMR, mass spectrometry and elemental analysis. In-vitro cytotoxicity of all three complexes was evaluated using COLO 205 (human colon cancer cell line) against the parent drug "oxaliplatin". The compound 4-amino-(transcyclohexane-1,2-diamine) platinum(II) (8) showed potent cytotoxicity with IC50 = 0.12 μM as compared to oxaliplatin (IC50 = 0.19 μM) and its aqueous solubility was found to be 16 mg/mL which is higher than oxaliplatin (8 mg/mL). The acute toxicity showed that the platinum complex (8) was less toxic than oxaliplatin. Molecular oxaliplatin-DNA complex structure indicates that the diaminocyclohexane (DACH) and Pt (II) showed interactions with N7 and O6 of GG base pairs of DNA helix. In this present study, it is interesting to note that all three platinum based anticancer agents with phthalate as the leaving group exhibited great cytotoxicity, less toxicity, good lipophilicity as well as better aqueous solubility. 2013 Bentham Science Publishers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65296-80-2